| SEPTEMBER 14, 2026 |
| Ownership | Founder-owned |
| Headcount | 13 FTEs |
| Headquarters | Boston, Massachusetts |
| Leadership | Andy Maltun, Co-Founder and Chief Executive Officer |
| Sell-side advisor | — |
| Ownership | PE-backed · Arsenal Capital Partners |
| Headquarters | Raleigh, North Carolina |
| Deal team | Mark A. Goldberg, MD, Chairman of the Board of Directors of Endpoint Clinical and Operating Partner at (Arsenal Capital Partners) |
| Buy-side advisor | — |